• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NOX2在入球小动脉反应性调节中的作用。

Role of NOX2 in the regulation of afferent arteriole responsiveness.

作者信息

Carlström Mattias, Lai En Yin, Ma Zufu, Patzak Andreas, Brown Russell D, Persson A Erik G

机构信息

Dept. of Medical Cell Biology, Biomedical Centre, Box 571, SE-75123 Uppsala, Sweden.

出版信息

Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R72-9. doi: 10.1152/ajpregu.90718.2008. Epub 2008 Nov 5.

DOI:10.1152/ajpregu.90718.2008
PMID:18987286
Abstract

NADPH oxidases (NOX) are the major source of reactive oxygen species (ROS) in the vasculature and contribute to the control of renal perfusion. The role of NOX2 in the regulation of blood pressure and afferent arteriole responsiveness was investigated in NOX2(-/-) and wild-type mice. Arteriole constrictions to ANG II (10(-14)-10(-6) mol/l) were weaker in NOX2(-/-) compared with wild types. N(omega)-nitro-l-arginine methyl ester (l-NAME; 10(-4) mol/l) treatment reduced basal diameters significantly more in NOX2(-/-) (-18%) than in wild types (-6%) and augmented ANG II responses. Adenosine (10(-11)-10(-4) mol/l) constricted arterioles of wild types but not of NOX2(-/-). However, simultaneous inhibition of adenosine type-2 receptors induced vasoconstriction, which was stronger in NOX2(-/-). Adenosine (10(-8) mol/l) enhanced the ANG II response in wild type, but not in NOX2(-/-). This sensitizing effect by adenosine was abolished by apocynin. Chronic ANG II pretreatment (14 days) did not change the ANG II responses in NOX2(-/-), but strengthened the response in wild types. ANG II pretreatment augmented the l-NAME response in NOX2(-/-) (-33%), but not in wild types. Simultaneous application of l-NAME and ANG II caused a stronger constriction in the NOX2(-/-) (-64%) than in wild types (-46%). Basal blood pressures were similar in both genotypes, however, chronic ANG II infusion elevated blood pressure to a greater extent in wild-type (15 +/- 1%) than in NOX2(-/-) (8 +/- 1%) mice. In conclusion, NOX2 plays an important role in the control of afferent arteriole tone and is involved in the contractile responses to ANG II and/or adenosine. NOX2 can be activated by elevated ANG II and may play an important role in ANG II-induced hypertension. NOX2-derived ROS scavenges nitric oxide, causing subsequent nitric oxide-deficiency.

摘要

烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX)是血管系统中活性氧(ROS)的主要来源,并参与肾灌注的调控。在NOX2基因敲除小鼠和野生型小鼠中研究了NOX2在血压调节和入球小动脉反应性中的作用。与野生型相比,NOX2基因敲除小鼠对血管紧张素II(ANG II,10⁻¹⁴ - 10⁻⁶ mol/L)的小动脉收缩作用较弱。用N⁻硝基⁻L⁻精氨酸甲酯(L⁻NAME,10⁻⁴ mol/L)处理后,NOX2基因敲除小鼠的基础管径显著减小(-18%),大于野生型小鼠(-6%),并且增强了对ANG II的反应。腺苷(10⁻¹¹ - 10⁻⁴ mol/L)使野生型小鼠的小动脉收缩,但对NOX2基因敲除小鼠无效。然而,同时抑制腺苷2型受体可诱导血管收缩,在NOX2基因敲除小鼠中更强。腺苷(10⁻⁸ mol/L)增强了野生型小鼠对ANG II的反应,但对NOX2基因敲除小鼠无效。腺苷的这种致敏作用被阿朴吗啡消除。慢性ANG II预处理(14天)未改变NOX2基因敲除小鼠对ANG II的反应,但增强了野生型小鼠的反应。ANG II预处理增强了NOX2基因敲除小鼠对L⁻NAME的反应(-33%),但对野生型小鼠无效。同时应用L⁻NAME和ANG II导致NOX2基因敲除小鼠的收缩作用更强(-64%),大于野生型小鼠(-46%)。两种基因型的基础血压相似,然而,慢性ANG II输注使野生型小鼠的血压升高幅度更大(15±1%),大于NOX2基因敲除小鼠(8±1%)。总之,NOX2在入球小动脉张力控制中起重要作用,并参与对ANG II和/或腺苷的收缩反应。NOX2可被升高的ANG II激活,可能在ANG II诱导的高血压中起重要作用。NOX2产生的ROS清除一氧化氮,导致随后的一氧化氮缺乏。

相似文献

1
Role of NOX2 in the regulation of afferent arteriole responsiveness.NOX2在入球小动脉反应性调节中的作用。
Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R72-9. doi: 10.1152/ajpregu.90718.2008. Epub 2008 Nov 5.
2
Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.肌红蛋白促进血管紧张素II诱导的肾入球小动脉收缩。
Am J Physiol Renal Physiol. 2017 May 1;312(5):F908-F916. doi: 10.1152/ajprenal.00394.2016. Epub 2017 Jan 4.
3
Adenosine A₁-receptor deficiency diminishes afferent arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment.腺苷 A₁-受体缺乏可减少一氧化氮抑制和血管紧张素 II 治疗期间的入球小动脉和血压反应。
Am J Physiol Regul Integr Comp Physiol. 2011 Dec;301(6):R1669-81. doi: 10.1152/ajpregu.00268.2011. Epub 2011 Oct 5.
4
Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension.高血压肾积水小鼠传入小动脉一氧化氮缺乏及腺苷反应增强
Hypertension. 2008 May;51(5):1386-92. doi: 10.1161/HYPERTENSIONAHA.108.111070. Epub 2008 Apr 7.
5
NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa.NOX2 是血管紧张素 II 在致密斑诱导产生超氧阴离子的主要来源。
Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R707-12. doi: 10.1152/ajpregu.00762.2009. Epub 2010 Jan 6.
6
Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice.血管紧张素II与一氧化氮在小鼠离体灌注传入小动脉中的相互作用。
J Am Soc Nephrol. 2001 Jun;12(6):1122-1127. doi: 10.1681/ASN.V1261122.
7
Angiotensin II slow-pressor hypertension enhances NMDA currents and NOX2-dependent superoxide production in hypothalamic paraventricular neurons.血管紧张素 II 缓激肽高血压增强了下丘脑室旁神经元中的 NMDA 电流和 NOX2 依赖性超氧化物的产生。
Am J Physiol Regul Integr Comp Physiol. 2013 Jun 15;304(12):R1096-106. doi: 10.1152/ajpregu.00367.2012. Epub 2013 Apr 10.
8
Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.内皮素-1转基因小鼠肾小球入球小动脉的血管紧张素II敏感性
Nephrol Dial Transplant. 2005 Dec;20(12):2681-9. doi: 10.1093/ndt/gfi136. Epub 2005 Sep 27.
9
Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice.血红素加氧酶-2基因敲除小鼠的血压和肾血流反应
Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1822-8. doi: 10.1152/ajpregu.00319.2009. Epub 2009 Oct 21.
10
Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia.含 Nox2 的 NADPH 氧化酶增强的超氧化物产生导致高胆固醇血症期间的大脑动脉功能障碍。
Stroke. 2010 Apr;41(4):784-9. doi: 10.1161/STROKEAHA.109.575365. Epub 2010 Feb 18.

引用本文的文献

1
NADPH oxidases: redox regulation of cell homeostasis and disease.烟酰胺腺嘌呤二核苷酸磷酸氧化酶:细胞稳态与疾病的氧化还原调节
Physiol Rev. 2025 Jul 1;105(3):1291-1428. doi: 10.1152/physrev.00034.2023. Epub 2025 Jan 15.
2
Oxidative Stress in Kidney Injury and Hypertension.肾脏损伤与高血压中的氧化应激
Antioxidants (Basel). 2024 Nov 27;13(12):1454. doi: 10.3390/antiox13121454.
3
Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseases.Klotho:中枢神经系统疾病中的分子机制和新兴治疗策略。
Mol Biol Rep. 2024 Aug 17;51(1):913. doi: 10.1007/s11033-024-09862-2.
4
Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions.糖尿病与肾脏并发症:病理生理学、生物标志物及治疗干预概述
Biomedicines. 2024 May 15;12(5):1098. doi: 10.3390/biomedicines12051098.
5
Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging.血管发病机制与衰老中的氧化应激、还原应激和抗氧化剂
Antioxidants (Basel). 2023 May 19;12(5):1126. doi: 10.3390/antiox12051126.
6
Nitric Oxide Signalling in Descending Vasa Recta after Hypoxia/Re-Oxygenation.缺氧/复氧后降支直小血管中的一氧化氮信号转导。
Int J Mol Sci. 2022 Jun 24;23(13):7016. doi: 10.3390/ijms23137016.
7
Renal NOXA1/NOX1 Signaling Regulates Epithelial Sodium Channel and Sodium Retention in Angiotensin II-induced Hypertension.肾源性 NOXA1/NOX1 信号调节血管紧张素 II 诱导的高血压中的上皮钠通道和钠潴留。
Antioxid Redox Signal. 2022 Mar;36(7-9):550-566. doi: 10.1089/ars.2021.0047.
8
Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy.慢性肾脏病中的氧化应激标志物,重点关注糖尿病肾病
Antioxidants (Basel). 2020 Sep 27;9(10):925. doi: 10.3390/antiox9100925.
9
Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread.慢性肾脏病发病机制和演变中的氧化应激:解开阿里阿德涅的线团。
Int J Mol Sci. 2019 Jul 29;20(15):3711. doi: 10.3390/ijms20153711.
10
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation.血管一氧化氮和活性氧的来源及其调节。
Physiol Rev. 2019 Jan 1;99(1):311-379. doi: 10.1152/physrev.00036.2017.